These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8955409)

  • 61. Structural basis of extended spectrum TEM beta-lactamases. Crystallographic, kinetic, and mass spectrometric investigations of enzyme mutants.
    Maveyraud L; Saves I; Burlet-Schiltz O; Swarén P; Masson JM; Delaire M; Mourey L; Promé JC; Samama JP
    J Biol Chem; 1996 May; 271(18):10482-9. PubMed ID: 8631844
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 beta-lactamase.
    Doucet N; De Wals PY; Pelletier JN
    J Biol Chem; 2004 Oct; 279(44):46295-303. PubMed ID: 15326193
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mapping catalytically important regions of an enzyme using two-codon insertion mutagenesis: a case study correlating beta-lactamase mutants with the three-dimensional structure.
    Zebala J; Barany F
    Gene; 1991 Apr; 100():51-7. PubMed ID: 2055479
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants.
    Kernodle DS; McGraw PA; Stratton CW; Kaiser AB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):420-5. PubMed ID: 2334154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interactions between active-site serine beta-lactamases and so-called beta-lactamase-stable antibiotics. Kinetic and molecular modelling studies.
    Matagne A; Lamotte-Brasseur J; Frère JM
    Eur J Biochem; 1993 Oct; 217(1):61-7. PubMed ID: 8223587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography.
    Kernodle DS; Zygmunt DJ; McGraw PA; Chipley JR
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2177-83. PubMed ID: 2073108
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Substitution of Asp for Asn at position 132 in the active site of TEM beta-lactamase. Activity toward different substrates and effects of neighboring residues.
    Osuna J; Viadiu H; Fink AL; Soberón X
    J Biol Chem; 1995 Jan; 270(2):775-80. PubMed ID: 7822310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Single amino acid mutations block a late step in the folding of beta-lactamase from Staphylococcus aureus.
    Craig S; Hollecker M; Creighton TE; Pain RH
    J Mol Biol; 1985 Oct; 185(4):681-7. PubMed ID: 3877172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 beta-lactamase crystal structure.
    Boissinot M; Levesque RC
    J Biol Chem; 1990 Jan; 265(2):1225-30. PubMed ID: 2295609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.
    Yuan J; Chow DC; Huang W; Palzkill T
    J Mol Biol; 2011 Mar; 406(5):730-44. PubMed ID: 21238457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Site-directed mutagenesis of glutamate 166 in two beta-lactamases. Kinetic and molecular modeling studies.
    Guillaume G; Vanhove M; Lamotte-Brasseur J; Ledent P; Jamin M; Joris B; Frère JM
    J Biol Chem; 1997 Feb; 272(9):5438-44. PubMed ID: 9038144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles.
    Kernodle DS; Stratton CW; McMurray LW; Chipley JR; McGraw PA
    J Infect Dis; 1989 Jan; 159(1):103-8. PubMed ID: 2783329
    [No Abstract]   [Full Text] [Related]  

  • 73. Pre-steady state beta-lactamase kinetics. Observation of a covalent intermediate during turnover of a fluorescent cephalosporin by the beta-lactamase of STaphylococcus aureus PC1.
    Anderson EG; Pratt RF
    J Biol Chem; 1981 Nov; 256(22):11401-4. PubMed ID: 6975275
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanism of inhibition of the PC1 beta-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group.
    Faraci WS; Pratt RF
    Biochemistry; 1985 Feb; 24(4):903-10. PubMed ID: 3873255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isolation of a Staphylococcus aureus beta-lactamase-dicloxacillin complex and kinetic studies on the reactivation of the enzyme.
    Hardy LW; Kirsch JF
    Arch Biochem Biophys; 1989 Jan; 268(1):338-48. PubMed ID: 2783544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Two alternative modes for optimizing nylon-6 byproduct hydrolytic activity from a carboxylesterase with a beta-lactamase fold: X-ray crystallographic analysis of directly evolved 6-aminohexanoate-dimer hydrolase.
    Ohki T; Shibata N; Higuchi Y; Kawashima Y; Takeo M; Kato D; Negoro S
    Protein Sci; 2009 Aug; 18(8):1662-73. PubMed ID: 19521995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unexpected influence of a C-terminal-fused His-tag on the processing of an enzyme and on the kinetic and folding parameters.
    Ledent P; Duez C; Vanhove M; Lejeune A; Fonzé E; Charlier P; Rhazi-Filali F; Thamm I; Guillaume G; Samyn B; Devreese B; Van Beeumen J; Lamotte-Brasseur J; Frère JM
    FEBS Lett; 1997 Aug; 413(2):194-6. PubMed ID: 9280280
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selection and application of antibodies modifying the function of beta-lactamase.
    Bibi E; Laskov R
    Biochim Biophys Acta; 1990 Aug; 1035(2):237-41. PubMed ID: 2118387
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The structures and catalytic mechanisms of active-site serine beta-lactamases.
    Lamotte-Brasseur J; Knox J; Kelly JA; Charlier P; Fonzé E; Dideberg O; Frére JM
    Biotechnol Genet Eng Rev; 1994; 12():189-230. PubMed ID: 7727028
    [No Abstract]   [Full Text] [Related]  

  • 80. Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a beta-lactamase.
    Rahil J; Pratt RF
    Biochemistry; 1994 Jan; 33(1):116-25. PubMed ID: 8286328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.